Literature DB >> 8659764

Positioning the pacing esophageal stethoscope for transesophageal atrial pacing without P-wave recording: implications for transesophageal ventricular pacing.

J V Roth1, J D Brody, E J Denham.   

Abstract

This study determined guidelines for positioning a new pacing esophageal stethoscope (PES) used for transesophageal atrial pacing (TEAP) without having to record esophageal P waves. In 44 patients with heights ranging from 142 cm (4'8") to 193 cm (6'4"), the PES was inserted to a depth of insertion (DOI) of 43 cm. As the PES was withdrawn, TEAP thresholds were determined at every DOI in 1-cm intervals between 43 and 25 cm DOI inclusive. TEAP was accomplished in all 44 patients. The minimum TEAP threshold (mean +/- SD 10.8 +/- 4.0 mA) was < or = 17 mA in 43 of 44 patients (98%). Except for one patient, TEAP could be accomplished over a 9- to 19-cm (mean +/- SD, 13.7 +/- 2.8 cm) wide range of DOI. Unintentional transesophageal ventricular pacing (TEVP) occurred in 15 of 44 (34%) of patients. TEVP occurred over a 1- to 7-cm (mean +/- SD, 3.7 +/- 1.7 cm) wide range of DOI; the minimum TEVP threshold averaged 30.4 +/- 6.4 mA. TEAP was consistently accomplished at DOIs more proximal than where TEVP could occur and with lower currents than that required for TEVP. An insertion depth, in centimeters, equal to half of the patient's height, in inches, produced successful TEAP in all 44 patients; the minimum TEAP threshold occurred on average at a DOI 2.6 cm more proximal. Asynchronous TEVP can be avoided by using lower currents at shallow DOIs.

Entities:  

Mesh:

Year:  1996        PMID: 8659764     DOI: 10.1097/00000539-199607000-00009

Source DB:  PubMed          Journal:  Anesth Analg        ISSN: 0003-2999            Impact factor:   5.108


  2 in total

1.  Efficacy of two commercially available cardiac pacing catheters for transesophageal atrial pacing in dogs.

Authors:  Emily H Chapel; Robert A Sanders
Journal:  J Vet Cardiol       Date:  2012-07-26       Impact factor: 1.701

2.  Non-invasive evaluation of ventricular refractoriness and its dispersion during ventricular fibrillation in patients with implantable cardioverter defibrillator.

Authors:  Jijian Luo; Carl Magnus Pripp; Eva Hertervig; Ole Kongstad; Erik Ljungström; S Bertil Olsson; Shiwen Yuan
Journal:  BMC Cardiovasc Disord       Date:  2004-06-09       Impact factor: 2.298

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.